Globus Medical (NYSE:GMED) today whaled on the consensus expecation with its second-quarter results and raised its outlook for the rest of the year. Audubon, Pa.-based Globus posted profits of $45.0 million, or 44¢ per share, on sales of $173.4 million for the three months ended June 30, for a bottom-line gain of 56.9% on sales growth […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Cerapedics launches P-15L peptide-enhanced bone graft IDE trial
Cerapedics said today it launched a new investigational device exemption trial looking to explore the safety and efficacy of its next-gen P-15L peptide enhanced bone graft in transforaminal interbody fusion surgeries. The Westminster, Colo.-based company said it has enrolled the first patients in the study, which aims to enroll a total of 364 patients with degenerative […]
Spine Wave raises $5m
Spine Wave has raised $5.3 million in a new round of debt financing, according to a recently posted SEC filing. Money in the round came from 29 unnamed investors, with the first sale noted as having occurred on July 17 of this year, according to the filing. The Shelton, Conn.-based company is looking for an […]
J&J seeks retraction of paper critical of Pinnacle hip study
Johnson & Johnson (NYSE:JNJ) are looking to get a scholarly paper challenging the validity an internal study of its DePuy subsidiary’s Pinnacle metal-on-metal hip systems retracted, according to a Stat News report. The study and journal paper were published by Brown University’s Dr. David Egilman and accused the J&J study of “grave fraudulence,” according to the […]
NuVasive wins FDA nod for Pulse spinal surgical automation platform
NuVasive (NSDQ:NUVA) said today it won FDA 510(k) clearance for its Pulse spinal surgical automation platform. The newly cleared Pulse system includes both 2D and 3D navigation and smart imaging capabilities with integrated neuromonitoring, surgical planning, radiation reduction and patient-specific rod bending tech, the San Diego-based company said. “Pulse seamlessly integrates multiple intraoperative technologies through an intuitive […]
Netflix’s ‘The Bleeding Edge’ blasts medtech & FDA
Netflix has unleashed a blistering indictment of the medical device industry, the FDA and doctors who accept money from medtech in its new documentary, ‘The Bleeding Edge,’ released today. The film depicts people who have suffered injuries and/or illnesses following placement of Bayer’s Essure sterilization device, Johnson & Johnson’s vaginal mesh, various manufacturers’ metal artificial […]
Johnson & Johnson wins $227m DoD spinal implant supply contract
Johnson & Johnson (NYSE:JNJ) has won a $227.6 million maximum fixed-price contract for spinal procedure implant packages with the US Department of Defense’s Logistics Agency, according to a newly released DoD posting. The contract comes with a one-year base and an additional four single year option periods, and will position J&J to supply spinal implant devices […]
Anika tops sales, EPS estimates with Q2 results
Anika Therapeutics (NSDQ:ANIK) reported its second-quarter financial results today, topping sales and earnings estimates on Wall Street. The Bedford, Mass.-based company posted profits of $10 million, or 69¢ per share, on sales of $30.5 million for the 3 months ended June 30, for bottom-line loss of -11% on sales loss of -9% compared with the same […]
Nevro shares plunge, rebound on court ruling in Boston Scientific spat
Anticipation over a court ruling in a patent spat between Nevro Corp. (NYSE:NVRO) and Boston Scientific (NYSE:BSX) sent NVRO shares plunging more than 26% yesterday, but after the actual ruling came out the stock surged some 24% today in pre-market trading. Judge Vince Chhabria of the U.S. District Court for Northern California, who ruled earlier this month […]
Smith & Nephew warns on first-gen Journey BCS knee revision rate
Smith & Nephew (NYSE:SNN) recently released an urgent field safety notice warning of issues with components in the first generation of its Journey BCS knee system that can lead to a higher rate of revisions than expected. The notice, originally sent in June, warned that post-market surveillance data showed that patients implanted with the first gen […]
Bone Biologics raises another $6m
Bone Biologics (OTC:BBLG) said today that it raised another $5.9 million for the orthobiologics it makes for spinal fusion procedures. The round includes $3.9 million in equity and a $2 million credit facility, the Burlington, Mass.-based company said. Bone Biologics said it plans to use the proceeds for working capital, protein development and regulatory and clinical […]